Resolution Therapeutics
Gabriel Kent is a Senior Analytical Development Scientist at Resolution Therapeutics, previously having worked as a Research Associate-Analytical Development at Autolus Ltd. and as a Preclinical Development Research Assistant at BioCyto. Gabriel has a Master's degree in Immunotherapeutics from Trinity College Dublin and a Bachelor's degree in Genetics from Swansea University. Gabriel's experience includes assisting in the development and characterization of a nanoparticle-based drug delivery technology platform and conducting market research to identify potential therapeutics for neurodegeneration.
This person is not in any offices
Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.